PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) announced executive presentations at three investor conferences: UBS Global Healthcare Conference on Nov 11, 2025 at 3:30 p.m. EST, Jefferies Global Healthcare Conference on Nov 18, 2025 at 8:00 a.m. GMT / 3:00 a.m. EST, and Citi 2025 Global Healthcare Conference on Dec 4, 2025 at 10:30 a.m. EST.

All presentations will be webcast live and archived for 30 days on PTC's Investor Events and Presentations page. Users are advised to connect to the webcast several minutes early to ensure a timely connection.

Argus Oct 31 session

+0.29% close to close 0.8x rel. volume Open Argus

Details

News Market Reaction – PTCT

On Oct 31, the day this news came out, PTCT closed 0.29% above the previous close.

Data tracked by StockTitan Argus for the Oct 31 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARREN, N.J., Oct. 31, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

UBS Global Healthcare Conference 2025
Tuesday, Nov. 11 at 3:30 p.m. EST

Jefferies Global Healthcare Conference 2025
Tuesday, Nov. 18 at 8 a.m. GMT / 3:00 a.m. EST

Citi 2025 Global Healthcare Conference
Thursday, Dec. 4 at 10:30 a.m. EST

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes before the start of the webcast to ensure a timely connection.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.

For More Information:

Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302600780.html

SOURCE PTC Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will PTC Therapeutics (PTCT) present at the UBS Global Healthcare Conference 2025?

PTC will present on Nov 11, 2025 at 3:30 p.m. EST.

How can investors watch PTC Therapeutics (PTCT) presentations at the Nov–Dec 2025 conferences?

Presentations will be webcast live and available on PTC's Investor Events and Presentations page.

Will PTC Therapeutics (PTCT) archive the conference webcasts and for how long?

Yes. Webcasts will be archived for 30 days following each presentation.

What time will PTC Therapeutics (PTCT) present at the Jefferies Global Healthcare Conference 2025 in GMT and EST?

The Jefferies presentation is scheduled for Nov 18, 2025 at 8:00 a.m. GMT / 3:00 a.m. EST.

When is PTC Therapeutics (PTCT) scheduled to present at the Citi 2025 Global Healthcare Conference?

PTC is scheduled to present on Dec 4, 2025 at 10:30 a.m. EST.

Any tips for ensuring a smooth connection to the PTC Therapeutics (PTCT) webcast?

PTC recommends connecting to the webcast several minutes before the scheduled start to ensure a timely connection.